Triplet combination of carboplatin, irinotecan, and etoposide in the first-line treatment of extensive small-cell lung cancer: a single-institution phase II study (Q33389117)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Triplet combination of carboplatin, irinotecan, and etoposide in the first-line treatment of extensive small-cell lung cancer: a single-institution phase II study |
scientific article |
Statements
1 reference
Triplet combination of carboplatin, irinotecan, and etoposide in the first-line treatment of extensive small-cell lung cancer: a single-institution phase II study (English)
1 reference
Andriani Charpidou
1 reference
Sophia Tsagouli
1 reference
Sotirios Tsimpoukis
1 reference
Antonios Vassias
1 reference
Nektaria Makrilia
1 reference
Grigorios Stratakos
1 reference
Ioannis Gkiozos
1 reference
Kostas Syrigos
1 reference
1 July 2010
1 reference
1 reference
21
1 reference
651-655
1 reference
Identifiers
1 reference
1 reference